ARS Pharmaceuticals Inc. (SPRY) PE Ratio

ARS Pharmaceuticals Inc. (SPRY) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.

PE Ratio Data

PeriodPE Ratio
2021-12-31-3.77
2022-12-31-11.09
2023-12-31-16.93
2024-12-31120.63
2025-12-31-5.55

Get ARS Pharmaceuticals Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =PERatio("SPRY")

BUY NOW